Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Rule 8.1- OJSC Polyus Gold

10 Jul 2009 08:38

RNS Number : 4579V
Renaissance Capital Limited
10 July 2009
 



  FORM 8.1  

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1)

Subsidiaries of Renaissance Capital Holdings Limited trading under the Renaissance Capital brand

 

Company dealt in

OJSC Polyus Gold

 

Class of relevant security to which the dealings being disclosed relate (Note 2)

 

1 RUB ordinary (OJSC Polyus Gold)

Date of dealing

9 July 2009

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

240,378 (0.12%)

224,406 (0.12%)

(2) Derivatives (other than options)

1,240,000 (0.65%)

(3) Options and agreements to purchase/sell

Total

 240,378 (0.12%)

1,494,406 (0.78%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

10,216 ordinary shares

21,124 ordinary shares

3,000 ADRs (conversion ratio 1 ADR:0.5 share)

USD 36.024

RUR 1137.000

USD 18.500

USD 35.281

RUR 915.264

USD 18.500

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

1,124 ordinary shares

30,216 ordinary shares

USD 35.775

RUR 1144.910

USD 35.447

RUR 915.264

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5) 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

10 July 2009

 

Contact name

Bridget Andrews

 

Telephone number

020 7367 7988

 

Name of offeree/offeror with which associated

Jenington International Inc (an indirect wholly owned subsidiary of OJSC Polyus Gold) 

 

Specify category and nature of associate status (Note 10)

Acting in concert as a result of a 50% less one-half of one share ownership of Renaissance Financial Holdings Limited by ONEXIM Group.

 

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8

DETAILS OF OPEN POSITIONS 

(This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name,

e.g. call option

Written or purchased

Number of securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

 Total return swap

Written

1,750,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

24 November 2009

Total return swap

Written

730,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

17 July 2009

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given.  Full details of any  existing agreements to purchase or to sell  should also be given on this form.  

2. For all prices and other monetary amounts, the currency must be stated.

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCDBLBFKDBXBBD
Date   Source Headline
30th May 20085:50 pmRNSOnexim offer
27th May 20083:11 pmRNSNotice of FSA review
27th May 20087:00 amRNSManagement stance on Kazimir
27th May 20087:00 amRNSConsolidation of 97,5% of Mat
23rd May 200812:59 pmRNSNotice of AGM
21st May 20083:58 pmRNSBoard resolutions
20th May 20082:33 pmRNSOffer received
17th Apr 20083:15 pmRNSRosprirodnadzor inspection
7th Apr 20081:09 pmRNSEGM results
2nd Apr 20088:19 amRNSAgreement with RusHydro
31st Mar 20081:06 pmRNSChertovo Koryto JORC Audit
27th Mar 200812:02 pmRNSGlass Lewis recommendation
25th Mar 200812:52 pmRNSRiskmetrics recommendation
11th Mar 20082:47 pmRNSBoard meeting results
21st Feb 20084:41 pmRNSBoard meeting results
20th Feb 20085:01 pmRNSnew licennes
20th Feb 20083:07 pmRNSAgreement with Irkutsk Region
14th Feb 200811:01 amRNSNew appointments
31st Jan 20081:10 pmRNSOperating Results 2007
29th Jan 20089:40 amRNSBoard meeting results
28th Jan 20083:53 pmRNSBlockListing 6 Monthly Return
25th Jan 20085:30 pmRNSNotice of EGM
20th Dec 200712:39 pmRNSTitimukhta reserves confirmed
18th Dec 20079:35 amRNSBoard meeting results
10th Dec 20073:29 pmRNSAuction won (Doroninskoye)
5th Dec 20073:06 pmRNSAuction won
30th Nov 20072:09 pmRNSAuction won
14th Nov 20075:02 pmRNSProject parameters approval
29th Oct 20078:05 amRNSAgreement announcement
16th Oct 20071:43 pmRNSNew appointments
15th Oct 20072:16 pmRNS1H07 Results Conference Call
12th Oct 20074:21 pmRNSPLZL - H1 Financial results
12th Oct 20073:07 pmRNSH1 2007 Financial Results
14th Sep 20073:01 pmRNSOption plan
12th Sep 20078:30 amRNSNotice of EGM
11th Sep 20078:45 amRNSNatalka JORC Audit
14th Aug 20072:42 pmRNSDeputy General Director
1st Aug 20077:12 amRNSConference call
31st Jul 20078:47 amRNS1H2007 production results
16th Jul 20077:18 amRNSMill-3 Launch
6th Jul 200711:10 amRNSChairman of the Board
5th Jul 200712:53 pmRNSAnnual Information Update
29th Jun 200711:00 amRNSResult of AGM
28th Jun 20071:50 pmRNSAnnual Report and Accounts
21st Jun 20071:00 pmRNSAmendments to the Charter
21st Jun 20071:00 pmRNSBlocklisting Interim Review
19th Jun 200710:00 amRNSNatalka Feasibility study
7th Jun 200711:00 amRNS2006 IFRS Results
29th May 20077:15 amRNSNew CEO
14th May 20073:10 pmRNSResult of Meeting (New CEO)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.